The Use of Clinical Endpoints in the ZUMA-3 Trial

Video

Bijal Shah, MD, MS, and Eunice Wang, MD, discussed the use of clinical endpoints like CR, CRi, and CRh as they relate to the ZUMA-3 trial of CAR T cell therapy.

This content originally appeared on our sister site, OncLive.

Recent Videos
Barry J. Byrne, MD, PhD, the chief medical advisor of Muscular Dystrophy Association (MDA) and a physician-scientist at the University of Florida
John Brandsema, MD, a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia
Chun-Yu Chen, PhD, a research scientist at Seattle Children’s Research Institute
William Chou, MD, on Targeting Progranulin With Gene Therapy for Frontotemporal Dementia
Alexandra Collin de l’Hortet, PhD, the head of therapeutics at Epic Bio
David Dimmock, MBBS, on Accelerating Therapy Discovery and Approval With AI David Dimmock, MBBS, on Accelerating Therapy Discovery and Approval With AI
Joshua M. Hare, MD, on Working to Address Unmet Needs in Alzheimer Disease With Lomecel-B Cell Therapy
John Finn, PhD, the chief scientific officer of Tome Biosciences
David Dimmock, MBBS, on a Promising Case Study of Ultra-Rare, AI-Guided, ASO Development
Related Content
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – September 13, 2024

CGTLive Staff
September 13th 2024
Article

Review top news and interview highlights from the week ending September 13, 2024.

Around the Helix: Cell and Gene Therapy Company Updates – September 11, 2024

Around the Helix: Cell and Gene Therapy Company Updates – September 11, 2024

Noah Stansfield
September 11th 2024
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Xandra Breakefield, PhD, investigator of neurology, Mass General Research Institute

Trying New Approaches to AAV Therapy for Glioblastoma

Xandra Breakefield, PhD;Noah Stansfield
September 11th 2024
Article

Xandra Breakefield, PhD, an investigator of neurology at Mass General Research Institute, discussed research from her grad student, Lisa Nieland, presented at the ASGCT 2024 meeting.

Lisa Nieland, a PhD candidate from Lieden University Medical Center and Breakefield Lab at Mass Gen

Slowing Tumor Growth in Glioblastoma With Novel AAV Therapy

Lisa Nieland;Noah Stansfield
September 10th 2024
Article

Lisa Nieland, a PhD candidate from Lieden University Medical Center and Breakefield Lab at Mass Gen, discussed her work presented at the ASGCT 2024 meeting.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – September 6, 2024

CGTLive Staff
September 6th 2024
Article

Review top news and interview highlights from the week ending September 6, 2024.

Cartesian Therapeutics Doses First Patient With mRNA CAR-T Descartes-15 in Trial for R/R Multiple Myeloma

Cartesian Therapeutics Doses First Patient With mRNA CAR-T Descartes-15 in Trial for R/R Multiple Myeloma

Noah Stansfield
September 6th 2024
Article

Pending the results of the trial, Cartesian plans to eventually evaluate Descartes-15 for the treatment of autoimmune diseases.

© 2024 MJH Life Sciences

All rights reserved.